These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10093002)

  • 41. Effect of simulated intragastric haemorrhage on gastric acid secretion, gastric motility, and serum gastrin.
    Fullarton GM; Boyd EJ; Crean GP; Hilditch TE; McColl KE
    Gut; 1990 May; 31(5):518-21. PubMed ID: 2351301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
    Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
    Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of oral nalmefene, an opiate-receptor antagonist, on meal-stimulated gastric acid secretion and serum gastrin concentration in man.
    Feldman M; Moore L; Walsh JH
    Regul Pept; 1985 Jul; 11(3):245-50. PubMed ID: 4059587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of antigastrin activity in vivo of CR 2194, a new R-4-benzamido-5-oxo-pentanoic acid derivative.
    Revel L; Ferrari F; Makovec F; Rovati LC; Impicciatore M
    Eur J Pharmacol; 1992 Jun; 216(2):217-24. PubMed ID: 1397008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
    Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F
    Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of glucagon on vagally induced gastric acid secretion in humans.
    Loud FB; Holst JJ; Christiansen J; Rehfeld JF
    Dig Dis Sci; 1988 Apr; 33(4):405-8. PubMed ID: 3349886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of sham feeding and a meal on plasma gastrin and duodenal pH in normal and duodenal ulcer patients.
    Eriksen CA; Buchanan KD; Cuschieri A
    Ann Surg; 1989 Apr; 209(4):411-7. PubMed ID: 2930286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on vagal activation of gastric acid secretion in man.
    Stenquist B
    Acta Physiol Scand Suppl; 1979; 465():1-31. PubMed ID: 291298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attenuation of the gastric acid and serum gastrin-lowering effects of the prostaglandin E2 analog enprostil.
    Baak LC; Jansen JB; Meijer JL; Lamers CB
    Clin Pharmacol Ther; 1993 Jun; 53(6):668-4. PubMed ID: 8513659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of cholecystokinin in the inhibition of gastric acid secretion in dogs.
    Konturek SJ; Bilski J; Tasler J; Cieszkowski M
    J Physiol; 1992; 451():477-89. PubMed ID: 1403819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia.
    Buchanan N; Laferla G; Hearns J; Buchanan KD; Crean GP; McColl KE
    Am J Med; 1986 Aug; 81(2A):40-3. PubMed ID: 3092653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of terbutaline, a beta 2-adrenoreceptor agonist, on gastric acid secretion and serum gastrin concentrations in humans.
    Thirlby RC; Richardson CT; Chew P; Feldman M
    Gastroenterology; 1988 Oct; 95(4):913-9. PubMed ID: 3410234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of gastrin, histamine, and acetylcholine in the gastric phase of acid secretion in anesthetized rats.
    Lloyd KC; Raybould HE; Taché Y; Walsh JH
    Am J Physiol; 1992 Apr; 262(4 Pt 1):G747-55. PubMed ID: 1348909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A physiological role for cholecystokinin as a regulator of gastrin secretion.
    Beglinger C; Hildebrand P; Meier R; Bauerfeind P; Hasslocher H; Urscheler N; Delco F; Eberle A; Gyr K
    Gastroenterology; 1992 Aug; 103(2):490-5. PubMed ID: 1634067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracolonic fat inhibits gastric acid secretion independent of gastrin release in the dog.
    Hashimoto T; Lluis F; Gomez G; Hill FL; Greeley GH; Thompson JC
    Dig Dis Sci; 1991 Jul; 36(7):888-92. PubMed ID: 2070700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of gastrin-stimulated gastric acid secretion by medium-chain triglycerides and long-chain triglycerides in healthy young men.
    Maas MI; Hopman WP; Katan MB; Jansen JB
    Regul Pept; 1996 Oct; 66(3):203-10. PubMed ID: 8916276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of calcium and gastrin on gastric acid secretion in duodenal ulcer patients.
    Christiansen J; Kirkegaard P; Olsen PS; Petersen B
    Gut; 1984 Feb; 25(2):174-7. PubMed ID: 6693045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selectivity and potency of new basic CCK-B antagonists.
    Rovati LC; D'Amato M; Peris W; Revel L; Makovec F
    Ann N Y Acad Sci; 1994 Mar; 713():395-7. PubMed ID: 8185200
    [No Abstract]   [Full Text] [Related]  

  • 59. Neurotensin inhibits meal-stimulated gastric acid secretion in man.
    Skov Olsen P; Holst Pedersen J; Kirkegaard P; Stadil F; Fahrenkrug J; Christiansen J
    Scand J Gastroenterol; 1983 Nov; 18(8):1073-6. PubMed ID: 6673077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CCKB/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disorders.
    Jensen RT
    Yale J Biol Med; 1996; 69(3):245-59. PubMed ID: 9165693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.